Gene therapy for type 1 diabetes. New approaches

Area of Science:

• Endocrinology
• Metabolic Diseases
• Gene Therapy

Background:

• Type 1 diabetes results from pancreatic beta-cell destruction, necessitating insulin injections.
• Current insulin therapy poses risks like hypoglycemia and weight gain, and may not prevent long-term complications.
• Gene therapy presents a potential solution for endogenous insulin production and improved diabetes management.

Purpose of the Study:

• To review recent advancements in gene therapy for type 1 diabetes.
• To explore strategies for ectopic insulin production and pancreatic beta-cell neogenesis.

Main Methods:

• Review of current literature on gene therapy approaches for type 1 diabetes.
• Focus on strategies involving insulin expression in ectopic tissues (liver, intestine) and promoting beta-cell regeneration.

Main Results:

• Exploration of constitutive and regulated insulin expression in the liver.
• Discussion of methods to enhance hepatic glucose oxidation.
• Examination of insulin production from intestinal cells.
• Review of islet cell neogenesis induction in the liver and pancreas.

Conclusions:

• Gene therapy holds significant potential for restoring endogenous insulin production in type 1 diabetes.
• Ectopic insulin production and beta-cell neogenesis are key strategies for improving glycemic control and preventing diabetes complications.